Oncoshot India Forges Strategic Alliance with Leading Healthcare Provider Jaslok Hospital in Mumbai to Advance Cancer Care

Pictured from left to right: Dr Milind Khadke, Director of Medical Service; Dr Nilesh Atre, Managing Director for Oncoshot India; and Dr Tapan Saikia, Director of Department of Oncosciences.

Oncoshot India is proud to announce a strategic partnership with Jaslok Hospital & Research Centre, one of the oldest and most esteemed super-speciality tertiary care hospitals in India. This partnership parallels Oncoshot India's cutting-edge real-time health insights exchange platform with Jaslok's rich legacy of providing comprehensive, compassionate, and patient-centred care. As Oncoshot India focuses on expediting clinical trial matching and offering valuable insights to the healthcare industry, this collaboration aims to leverage both entities' strengths for the greater benefit of oncologists, cancer patients, and the advancement of global cancer research. Together, we embark on a journey to redefine the landscape of cancer care and research, fostering innovation and health equity.   

As a cornerstone in India's healthcare landscape, Jaslok Hospital & Research Centre stands as a testament to decades of commitment to advancing medical care. Founded in the late 60s by philanthropist Seth Lokoomal Chanrai, the hospital has evolved into a private, multi-speciality institution, boasting 350 beds, 75 ICU beds, and over 300 consultants. With a vision to offer advanced health care to people of all races and creeds, Jaslok Hospital has been a pioneer in medical research, conducting numerous trials and collaborating with institutions globally. Its commitment to serving the less fortunate sections of society, with 20% of beds reserved for indigent and weaker sections, aligns seamlessly with Oncoshot India's mission of health equity. Jaslok's emphasis on training healthcare professionals worldwide and its recognition by the National Board of Examinations in 22 specialities underscores its position as a leader in the field. The partnership with Oncoshot India is poised to enhance these strengths further, bringing real-time health insights and innovative approaches to cancer care, ultimately benefitting patients, and advancing medical research on a global scale. Jaslok Hospital’s clinical oncology team is also headed by several leading oncologists from India, including Dr Suresh Advani, Dr Boman Dhabhar, Dr Tapan Saikia and Dr Ritu Jain.

The partnership between Jaslok Hospital and Oncoshot India is a significant step towards contributing to global advancements in cancer research and treatment. By leveraging Oncoshot India's real-time health insights exchange platform, Jaslok Hospital gains a unique opportunity to collaborate on international clinical trials. This global collaboration can attract leading researchers, industry experts, and pharmaceutical companies, fostering an environment where innovative ideas are exchanged across borders. Jaslok Hospital's participation in this network positions it as a key player in the global healthcare landscape, contributing valuable data and insights to cancer research on an international scale. This collaboration was possible with the kind support and guidance from Mr Jitendra Haryan, CEO; Dr Milind Khadke, CMO;  and Dr Tapan Saikia, head of oncoscience. 

‘Jaslok Hospital is a thought leader in promoting cutting-edge research and technology in healthcare. To this end, we find the collaboration with Oncoshot India very encouraging. The excellent operational rapport of the Oncoshot India team is also an asset in this collaboration. We are also looking forward to national and international reach via this OSI engagement in the Indian national oncology landscape,’ said Dr Khadke.

Looking ahead, the collaboration opens doors to a multitude of possibilities. The integration of Oncoshot India's advanced technology into Jaslok Hospital's systems not only streamlines current processes but also lays the foundation for future innovations. As the partnership evolves, there is potential for joint research initiatives, pioneering studies, and the development of cutting-edge treatments. This collaboration does not only represent an alliance; it paves the way for a sustained commitment to pushing the boundaries of cancer care. Patients at Jaslok Hospital can anticipate increased access to the latest advancements in oncology, positioning the institution as a beacon of progress and patient-centric care in the years to come. 

‘From my experience at Tata Memorial Hospital & Tata Memorial Centre, I am aware of the clinical importance of cancer clinical trials for cancer patients in India. Our oncosciences team at Jaslok Hospital is keenly looking forward to the clinical collaboration with Oncoshot India. So that we can leverage the benefits to the cancer patients and their families,’ said Dr Saikia.  

For more information about Jaslok Hospital & Research Centre, visit https://jaslokhospital.net/.